Unexpected [18F] Fluciclovine Uptake in Pilocytic Astrocytoma: A Pediatric Case Report
A 5-year-old asymptomatic boy underwent MRI, which revealed a mass lesion in the septum pellucidum suspected to be a glioma. [18F]Fluciclovine PET, which provides insight into amino acid metabolism, revealed high uptake (SUVmax, 2.37; TBR, 3.56), which was consistent with high-grade glioma. In contrast, [18F] Fluorodeoxyglucose PET showed low uptake (SUV max: 2.2; TBR: 0.29). Partial resection and histopathology confirmed pilocytic astrocytoma, a WHO grade 1 tumor, with KIAA1549-BRAF fusion. High [18F] Fluciclovine uptake in pilocytic astrocytoma may reflect amino acid transporter expression, which may lead to overestimation of the WHO grade. Awareness of this pitfall is essential in pediatric neuro-oncology.
Authors
- Hironobu Koga
- Shigeru Yamaguchi (ORCID: https://orcid.org/0000-0003-3710-5888)
- Kohsuke Kudo (ORCID: https://orcid.org/0000-0001-5351-9242)
- Shirô Watanabe (ORCID: https://orcid.org/0000-0002-7930-0975)
- Yukitomo Ishi (ORCID: https://orcid.org/0000-0003-4834-2619)
- Kenji Hirata (ORCID: https://orcid.org/0000-0003-0036-8975)
Institutions
- Hokkaido University (JP)
- Hokkaido University Hospital (JP)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1097/rlu.0000000000006233
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00